C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms

C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms

Alzheimer's disease (AD) stands as one of the most prevalent neurodegenerative disorders, characterized by a progressive decline in cognitive function, neuroinflammation, amyloid-beta (Aβ) plaques, and neurofibrillary tangles (NFTs). With the global aging population, the incidence of AD continu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoting Luo, Junyi Liang, Xue Lei, Fengqi Sun, Minghai Gong, Bin Liu, Zhongguang Zhou
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Brain Research Bulletin
Subjects:	Alzheimer’s disease C/EBPβ Neuroinflammation Lipid metabolism Aβ metabolism Tau phosphorylation
Online Access:	http://www.sciencedirect.com/science/article/pii/S0361923025000103
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Microglial C/EBPβ-Fcgr1 regulatory axis blocking inhibits microglial pyroptosis and improves neurological recovery
by: Jing Li, et al.
Published: (2025-01-01)

Vincristine Regulates C/EBP-β/TGF-β1 to Promote A1 Astrocyte Polarization and Induce Neuropathic Pain
by: Chen Y, et al.
Published: (2025-02-01)

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)

C/EBPβ Regulates HIF-1α-Driven Invasion of Non-Small-Cell Lung Cancer Cells
by: Seung Hee Seo, et al.
Published: (2024-12-01)

Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
by: Mei Wang, et al.
Published: (2025-02-01)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
by: Sijia He, et al.
Published: (2025-01-01)

Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01)

Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
by: Masahiro Hata, et al.
Published: (2025-01-01)

Targeting early tau pathology: probiotic diet enhances cognitive function and reduces inflammation in a preclinical Alzheimer’s model
by: Cassandra M. Flynn, et al.
Published: (2025-01-01)

Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01)

Detection of Endocarditis Associated Pili Genes in Enterococcus Faecalis Clinical Isolates
by: Ayat Ahmed Najm, et al.
Published: (2025-01-01)

Short-term variability of Alzheimer’s disease plasma biomarkers in a mixed memory clinic cohort
by: Frederikke Kragh Clemmensen, et al.
Published: (2025-01-01)

Lipid mediators in post-mortem brain samples from patients with Alzheimer's disease: A systematic review
by: Aidan D. Tyrrell, et al.
Published: (2025-02-01)

Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
by: Longsheng Xie, et al.
Published: (2025-01-01)

The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment
by: Fan Chen, et al.
Published: (2023-05-01)

Rotation errors in path integration are associated with Alzheimer’s disease tau pathology: a cross-sectional study
by: Lise Colmant, et al.
Published: (2025-02-01)

CD2AP deficiency aggravates Alzheimer’s disease phenotypes and pathology through p38 MAPK activation
by: Yan-Yan Xue, et al.
Published: (2024-12-01)

Globular-shaped Aβ oligomers have diverse mechanisms for promoting Aβ aggregations with the facilitation of fibril elongation
by: Hiroto Nakano, et al.
Published: (2025-02-01)

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
by: Ignacio Silva-Llanes, et al.
Published: (2025-01-01)

Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01)

IGF2BP2 Regulates the Progression of Alzheimer's Disease Through m6A‐Mediated NLRP3 Inflammasome
by: Wu Jingrui, et al.
Published: (2025-01-01)

Serum uric acid to creatinine ratio as a predictor of insulin resistance, β cell function, and metabolic syndrome in normal Korean adults: a cross-sectional study
by: Misuk Oh, et al.
Published: (2025-02-01)

Resensitizing β‐Lactams by Reprogramming Purine Metabolism in Small Colony Variant for Osteomyelitis Treatment
by: Tingwang Shi, et al.
Published: (2025-02-01)

Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration
by: Gao Han, et al.
Published: (2025-02-01)

Isoforsythiaside confers neuroprotection against Alzheimer’s disease by attenuating ferroptosis and neuroinflammation in vivo and in vitro
by: Chunyue Wang, et al.
Published: (2023-09-01)

Unveiling neurogenic biomarkers for the differentiation between sepsis patients with or without encephalopathy: an updated meta-analysis
by: Jiyun Hu, et al.
Published: (2025-02-01)

Pharmacological modulation of Sigma-1 receptor ameliorates pathological neuroinflammation in rats with diabetic neuropathic pain via the AKT/GSK-3β/NF-κB pathway
by: Yuyu An, et al.
Published: (2025-02-01)

OXA β-lactamases from Acinetobacter spp. are membrane bound and secreted into outer membrane vesicles
by: Lucia Capodimonte, et al.
Published: (2025-02-01)

Peripheral proteinopathy in neurodegenerative diseases
by: Bin Xu, et al.
Published: (2025-01-01)

Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
by: Hongtao Du, et al.
Published: (2025-01-01)

Insufficient Sleep and Alzheimer’s Disease: Potential Approach for Therapeutic Treatment Methods
by: Dieu Quynh Trinh, et al.
Published: (2024-12-01)

Effect of lipid peroxidation on the allergenicity and functional properties of soybean β-conglycinin (7S) and glycinin (11S)
by: Liying Ye, et al.
Published: (2023-05-01)

Lipid trajectories improve risk models for Alzheimer’s disease and mild cognitive impairment
by: Bruce A. Chase, et al.
Published: (2025-01-01)

Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
by: Marilena K. Theodoropoulou, et al.
Published: (2024-12-01)

In search of Alzheimer’s disease treatment methods: trends of clinical trials
by: G. Pakulaitė, et al.
Published: (2018-03-01)

Insulin resistance surrogates are associated with all-cause mortality and cardiovascular mortality in population with metabolic syndrome: a retrospective cohort study of NHANES
by: Jinhao Liao, et al.
Published: (2025-02-01)

Research progress on energy metabolism regulation in stored platelets
by: GAO Chengyan, et al.
Published: (2025-01-01)